Mario Negri Institute for Pharmacological Research: Diabetes Mellitus, Type 2 trials

The registry lists 10 Diabetes Mellitus, Type 2 studies with Mario Negri Institute for Pharmacological Research as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 6Phase 3 2No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• LSCI and Thermography in Diabetic Foot Patients Affected by Ulcer(s): (MY-FOOT-B)WithdrawnNCT05791929
• Insulin Treatment in Diabetic Older People With Heart Failure.TerminatedNCT03665350Phase 2
• Effects of Caloric Restriction in Obesity and Type 2 DiabetesCompletedNCT01930136Not applicable
• Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 DiabetesCompletedNCT01393808Phase 2
• Preventing Renal Functional Abnormalities With Calorie Restriction in Subjects With Abdominal Obesity and Type 2 Diabetes at Increased Renal and Cardiovascular RiskCompletedNCT01213212Phase 2
• Acetyl-L-Carnitine in Type 2 DiabetesCompletedNCT00984750Phase 3
• Acetylcarnitine and Insulin SensitivityCompletedNCT00393770Phase 2
• Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)CompletedNCT00157586Phase 3
• Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early NephropathyTerminatedNCT00157508Phase 2
• Ezetimibe and Simvastatin in Dyslipidemia of DiabetesCompletedNCT00157482Phase 2